-
European Patent Office拟授予 Genprex, Inc.基因疗法组合癌症治疗专利
Searching for your content... In-Language News Contact Us
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-05 15:26
-
美国专利商标局(USPTO)拟修 IPR 提审规则 加强单一争议程序
USPTO Operations USPTO Leadership & Staffing Changes to IPR Institution Process
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-05 15:26
-
日本专利局(JPO)在东京举办 “知识产权司法研讨会 2025”
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-05 15:26
-
EPO sponsors One Young World Summit in Munich
<p>The EPO holds a workshop with young leaders during event in Munich from 3 to 6 November</p>
来源: https://www.epo.org/en/news-events/news/feed
· 时间: 2025-11-05 10:07
-
EPO meets with CNH Industrial
<p>Exchanges on patent quality, plus impact of the Unitary Patent system and AI</p>
来源: https://www.epo.org/en/news-events/news/feed
· 时间: 2025-11-04 18:56
-
美国最高法院同意受理苹果与Masimo专利纠纷上诉案
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-04 09:21
-
韩国知识产权局(KIPO)发布AI专利审查新指南
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-04 09:21
-
日本特许厅与欧洲专利局加强专利审查合作机制
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-04 09:21
-
USPTO 大批驳回 IPR 挑战:首批十三件遭拒
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulin
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-04 09:21
-
USPTO拟对 IPR 制度进行剧烈收紧:或禁止重复挑战同一专利
The United States Patent and Trademark Office (USPTO) has published proposed regulations that would fundamentally transform the inter partes review (IPR) landscape, potentially eliminating IPR as a vi
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-04 09:21
-
在轨制造崛起:低轨 LOM 产业知识产权保护变得关键
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-04 08:57
-
Spectral Capital Corporation 表示专利申请已超 300 件,目标2025年超500件
SEATTLE, Nov. 3, 2025 /PRNewswire/ -- Spectral Capital Corporation (OTCQB: FCCN), a technology investment and development company focused on artificial intelligence, quantum computing, and hybrid AI-q
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-04 08:57
-
Lightbridge 收到来自 Eurasian Patent Office 的新专利允许通知
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-04 08:57
-
Actimed Therapeutics Ltd 在日本获授领导化合物构成专利
November 03, 2025 04:00 ET | Source: Actimed Therapeutics Actimed Therapeutics Patent expands IP protection for S-pindolol benzoate (ACM-001.1), reinforcing the global IP position of Actimed with gran
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-04 08:57
-
Final major MyEPO release of 2025
<p>Enhancements include new homepage and expanded self-management options, all developed in close collaboration with pilot users</p>
来源: https://www.epo.org/en/news-events/news/feed
· 时间: 2025-11-03 17:03
-
USPTO 新任局长称“继承的专利审查积压是一场垃圾场般的灾难” 承诺加速AI与审查效率
John Squires, who delivered his first public remarks in Washington, DC after becoming USPTO president
EPNAC.com
1 November 2025NewsPatentsSarah Speight
Squires: ‘Inherited patent backlog was an absolu
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-03 14:44
-
任天堂关键游戏专利申请遭日本特许厅质疑
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-03 12:46
-
中欧美日韩外观设计五局召開年度合作會議
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-03 12:46
-
New Candidate Support Programme builds stronger patent profession across Europe
<p>Fostering a more inclusive patent community, enhancing quality at source </p>
来源: https://www.epo.org/en/news-events/news/feed
· 时间: 2025-11-03 09:37
-
美国专利商标局将人工智能提升为首要审查工具
来源: https://watch.patwatch.com/featured
· 时间: 2025-11-02 10:02